HIGHLIGHTS
- who: Jiangbiao Xiong and collaborators from the The First Affiliated Hospital of Nanchang University, Nanchang, China have published the research: The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease, in the Journal: Disease Markers of 29/09/2022
- what: The study aimed to investigate the value of pulmonary function test (PFT) in evaluating and predicting pulmonary arterial hypertension (PAH) in patients with connective tissue disease (CTD). This study showed that 95% of patients with CTD-PAH had an FEV1/FVC above 70%. The results of this study showed . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.